Related Experiment Videos
Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensis
S B Singh1, D L Zink, M Williams
1Merck Research Laboratories, Rahway, NJ 07065, USA.
Abstract:
Farnesyl-protein transferase (FPTase) is a critical enzyme that participates in the post-translational modification of the Ras protein. Inhibitors of this enzyme have the potential of being novel anticancer agents for tumors in which the ras oncogene is found mutated and contributes to cell transformation. Continued screening of natural product extracts led to the isolation of kampanols, which are novel and specific inhibitors of FPTase. The most active kampanols exhibited IC50 values between 7 to 13 microM against human recombinant FPTase. The isolation, structure determination, and biological activity of these compounds are described.
Insights
New natural compounds called kampanols specifically inhibit farnesyl-protein transferase (FPTase), an enzyme crucial for Ras protein modification, offering potential as anticancer agents for mutated ras oncogene tumors.
Area of Science:
- Biochemistry
- Molecular Biology
- Natural Product Chemistry
Background:
- Farnesyl-protein transferase (FPTase) is essential for post-translational modification of the Ras protein.
- Mutated ras oncogenes drive cell transformation and are implicated in various cancers.
- FPTase inhibitors represent a potential therapeutic strategy for ras-driven tumors.
Purpose of the Study:
- To discover and characterize novel, specific inhibitors of FPTase from natural product extracts.
- To evaluate the anticancer potential of isolated compounds.
Main Methods:
- Screening of natural product extracts for FPTase inhibitory activity.
- Isolation and structure determination of active compounds (kampanols).
- Biochemical assays to determine the inhibitory potency (IC50) against human recombinant FPTase.
Main Results:
- Isolation of novel FPTase inhibitors, termed kampanols.
- Kampanols demonstrated specific inhibition of FPTase.
- The most potent kampanols exhibited IC50 values ranging from 7 to 13 microM against human recombinant FPTase.
Conclusions:
- Kampanols are novel and specific inhibitors of farnesyl-protein transferase.
- These compounds hold promise as potential anticancer agents for tumors with mutated ras oncogenes.
- Further investigation into kampanols' therapeutic efficacy is warranted.